Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-31

Clinical Trial Update: The Effects of Medical Cannabis in Children With Autistic Spectrum Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the effects of medical cannabis in children with autism spectrum disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Medical Cannabis (cannabis)

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Autism Spectrum Disorder | Phase 3 | Status: COMPLETED